IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Akdeniz Tıp Dergisi
  • Cilt: 11 Sayı: 2
  • The Effect of Different Serum Potassium Levels on Progression of Chronic Kidney Disease

The Effect of Different Serum Potassium Levels on Progression of Chronic Kidney Disease

Authors : İvo Gökmen, Ömer Celal Elçioğlu
Pages : 266-276
Doi:10.53394/akd.1482691
View : 55 | Download : 93
Publication Date : 2025-05-28
Article Type : Research Paper
Abstract :Objective: Hyperkalemia is the most commonelectrolyte imbalance in chronic kidney disease (CKD). Research within the CKD population suggests a potential link between hyperkalemia, hypokalemia, fluctuations in serum potassium (sK+) levels, and CKD progression.This study aimed to clarify how different sK+ levels affect CKD progression. Material and Methods:eGFR levels were assessed, identifying patients with decreased eGFR. A total of 1171 patients were included .sK+ levels were analyzed in groups, and a Binary Logistic Regression model was employed for GFR decrease prediction. Results: The mean sK+ level was 4.6 ± 0.4 mmol/l. Hyperkalemia was observed in 26.1% of patients, with hypokalemia at only 0.6%. During the follow-up, eGFR levels exhibited a significant decrease. A negative correlation was observed between sK+ level and the final eGFR of patients. Specifically, sK+ levels ranging from 5.0 to 5.5 mmol/l and instances of hyperkalemia were linked with decreased eGFR, while sK+ levels at 3.5-4.0 mmol/l demonstrated a protective effect against eGFR decrease. Adjusting for albumin, calcium, urea levels, ACEi/ARB usage, β-AR blockers intake, and CCB administration in the regression model revealed that sK+ levels at 5.0-5.5 mmol/l and hyperkalemia independently contributed to eGFR decrease. Conversely, sK+ levels at 3.5-4.0 mmol/l emerged as a protective factor against eGFR decrease. Conclusion: Our findings underscore the association of hyperkalemia and sK+ levels at 5.0-5.5 mmol/l with decreased eGFR among CKD patients. Conversely, maintaining sK+ levels at 3.5-4.0 mmol/l appears to mitigate the risk of eGFR decrease. Thus, vigilant sK+ monitoring is crucial in managing CKD effectively.
Keywords : Kronik Böbrek Hastalığı, Glomerüler Filtrasyon Hızı, Potasyum Seviyesi, Hiperkalemi, Hipokalemi

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2026